FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Akorn Rifampin For Injection Recall

RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only

Akorn, Inc. · Lake Forest, IL

Risk level
Class III
Reported by FDA
Nov 25, 2015
Recall ID
D-0231-2016
Check your lot numberHow we source this data

Summary

Akorn recalled Rifampin For Injection starting Aug 20, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0231-2016 on Nov 25, 2015. Reason: Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity. Status: Terminated.

Why it was recalled

Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity.

Product description

RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.

Lot numbers, UPCs & expiration codes

Lot #: 14RIF1(A), Expiry: 9/30/2016.

Where it was sold

US: Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0231-2016
Classification
Class III
Status
Terminated
Recall initiated
Aug 20, 2015
FDA report date
Nov 25, 2015
Quantity
6861 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-0231-2016, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
72192
Address
1925 W. Field Court, Suite 300
Code information
Lot #: 14RIF1(A), Expiry: 9/30/2016.
Postal code
60045
Report date
Nov 25, 2015
Product type
Drugs
Recall number
D-0231-2016
Classification
Class III
Recalling firm
Akorn, Inc.
Product quantity
6861 Vials
Termination date
Jan 26, 2017
Reason for recall
Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.
Distribution pattern
US: Nationwide
Recall initiation date
Aug 20, 2015
Initial firm notification
Letter
Center classification date
Nov 13, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0231-2016, published Nov 25, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls